Status:
COMPLETED
Azithromycin in the Prevention of Lung Injury in Premature Newborn
Lead Sponsor:
Hospital de Clinicas de Porto Alegre
Conditions:
Bronchopulmonary Dysplasia
Eligibility:
All Genders
1-72 years
Phase:
PHASE4
Brief Summary
The introduction of invasive mechanical ventilation in the treatment of preterm infants works as an adjuvant in the treatment of acute respiratory failure, which has resulted in significantly signific...
Detailed Description
The nature of lung injury induced by mechanical ventilation is clearly established, including the release of immunoinflammatory mediators. However, safe drug therapy that decreases its severity is not...
Eligibility Criteria
Inclusion
- preterm infants of less than 37 weeks of gestational age who have undergone mechanical ventilation within the first 72 hours of life
Exclusion
- Major congenital malformations or chromosomal syndromes Mothers carrying the HIV virus.
Key Trial Info
Start Date :
August 28 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 13 2016
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03485703
Start Date
August 28 2012
End Date
April 13 2016
Last Update
April 2 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.